Pharmacogenomics in Primary Care: A Crucial Entry Point for Global Personalized Medicine?
作者信息
Bartlett Gillian, Zgheib Nathalie, Manamperi Aresha, Wang Wei, Hizel Candan, Kahveci Rabia, Yazan Yasemin
机构信息
Department of Family Medicine, McGill University, Montreal, QC, Canada.
出版信息
Curr Pharmacogenomics Person Med. 2012;10(2):101-105. doi: 10.2174/187569212800626430.
Abstract
摘要
相似文献
1
Pharmacogenomics in Primary Care: A Crucial Entry Point for Global Personalized Medicine?基层医疗中的药物基因组学：全球个性化医疗的关键切入点？
Curr Pharmacogenomics Person Med. 2012;10(2):101-105. doi: 10.2174/187569212800626430.
2
Pharmacogenomics: Driving Personalized Medicine.药物基因组学：推动个性化医疗。
Pharmacol Rev. 2023 Jul;75(4):789-814. doi: 10.1124/pharmrev.122.000810. Epub 2023 Mar 16.
3
4th ESPT Conference: pharmacogenomics and personalized medicine - research progress and clinical implementation.第四届 ESPT 会议：药物基因组学与个性化医学——研究进展与临床实践。
Pharmacogenomics. 2019 Oct;20(15):1063-1069. doi: 10.2217/pgs-2019-0095.
4
An inter-professional approach to personalized medicine education: one institution's experience.个性化医学教育的跨专业方法：一所机构的经验。
Per Med. 2015 Mar;12(2):129-138. doi: 10.2217/pme.14.63.
5
Evaluating the current level of pharmacists' pharmacogenomics knowledge and its impact on pharmacogenomics implementation.评估药师当前的药物基因组学知识水平及其对药物基因组学实施的影响。
Pharmacogenomics. 2020 Nov;21(16):1179-1189. doi: 10.2217/pgs-2020-0076. Epub 2020 Oct 29.
6
personalized medicine and pharmacogenomics: ethical and social challenges.个性化医疗与药物基因组学：伦理和社会挑战
Per Med. 2005 Mar;2(1):29-35. doi: 10.1517/17410541.2.1.29.
7
Golden Helix Pharmacogenomics Days: educational activities on pharmacogenomics and personalized medicine.金螺旋遗传药理学日：关于遗传药理学和个体化医学的教育活动。
Pharmacogenomics. 2012 Apr;13(5):525-8. doi: 10.2217/pgs.12.22.
8
Theranostics in primary care: pharmacogenomics tests and beyond.初级保健中的治疗学：药物基因组学检测及其他。
Expert Rev Mol Diagn. 2012 Nov;12(8):841-55. doi: 10.1586/erm.12.115.
9
Translating pharmacogenomics into personalized medicine and drug development.将药物基因组学转化为个性化医疗和药物研发。
Per Med. 2012 Jan;9(1):93-97. doi: 10.2217/pme.11.78.
10
Design and Implementing Pharmacogenomics Study in Cancer.设计和实施癌症的药物基因组学研究。
Adv Exp Med Biol. 2019;1168:43-77. doi: 10.1007/978-3-030-24100-1_4.
引用本文的文献
1
Implementation of Pharmacogenetics in Primary Care: A Multi-Stakeholder Perspective.基层医疗中药物遗传学的实施：多利益相关者视角
Front Genet. 2020 Jan 31;11:10. doi: 10.3389/fgene.2020.00010. eCollection 2020.
2
A stepwise approach to implementing pharmacogenetic testing in the primary care setting.在初级保健环境中逐步实施药物遗传学检测的方法。
Pharmacogenomics. 2019 Oct;20(15):1103-1112. doi: 10.2217/pgs-2019-0053.
3
The Routine Clinical use of Pharmacogenetic Tests: What it Will Require?临床常规使用药物基因组学检测：需要什么？
Pharm Res. 2017 Aug;34(8):1544-1550. doi: 10.1007/s11095-017-2128-0. Epub 2017 Feb 24.
4
The combinatorial approach of laser-captured microdissection and reverse transcription quantitative polymerase chain reaction accurately determines HER2 status in breast cancer.激光捕获显微切割与逆转录定量聚合酶链反应的组合方法可准确确定乳腺癌中的 HER2 状态。
Biomark Res. 2016 Apr 7;4:8. doi: 10.1186/s40364-016-0062-7. eCollection 2016.
5
Scientific challenges and implementation barriers to translation of pharmacogenomics in clinical practice.临床实践中药物基因组学转化的科学挑战与实施障碍。
ISRN Pharmacol. 2013;2013:641089. doi: 10.1155/2013/641089. Epub 2013 Feb 28.
本文引用的文献
1
Clinical implementation of pharmacogenetics: a nonrepresentative explorative survey to participants of WorldPharma 2010.临床实施药物遗传学：对 2010 年世界制药学会议参与者的非代表性探索性调查。
Pharmacogenomics. 2011 Jul;12(7):1051-9. doi: 10.2217/pgs.11.42.
2
Evaluation of the genetic diversity of domain II of Plasmodium vivax Apical Membrane Antigen 1 (PvAMA-1) and the ensuing strain-specific immune responses in patients from Sri Lanka.评估来自斯里兰卡患者的恶性疟原虫顶膜蛋白 1（PvAMA-1）结构域 II 的遗传多样性以及由此产生的针对特定株系的免疫应答。
Vaccine. 2011 Oct 6;29(43):7491-504. doi: 10.1016/j.vaccine.2011.07.029. Epub 2011 Jul 23.
3
Attitudes of health care professionals toward pharmacogenetic testing.医疗保健专业人员对药物遗传学检测的态度。
Mol Diagn Ther. 2011 Apr 1;15(2):115-22. doi: 10.1007/BF03256401.
4
Asia-Pacific Health 2020 and Genomics without Borders: Co-Production of Knowledge by Science and Society Partnership for Global Personalized Medicine.《2020年亚太地区健康与无国界基因组学：科学与社会伙伴关系促进全球个性化医疗的知识共同生产》
Curr Pharmacogenomics Person Med. 2011 Mar 1;9(1):1-5. doi: 10.2174/187569211794728841.
5
Genomics. Deflating the genomic bubble.基因组学。戳破基因组泡沫。
Science. 2011 Feb 18;331(6019):861-2. doi: 10.1126/science.1198039.
6
Emerging issues in public health: a perspective on China's healthcare system.新兴公共卫生问题：对中国医疗体系的观察视角。
Public Health. 2011 Jan;125(1):9-14. doi: 10.1016/j.puhe.2010.10.009. Epub 2010 Dec 17.
7
Influence of CYP2C9 and VKORC1 polymorphisms on warfarin and acenocoumarol in a sample of Lebanese people.CYP2C9 和 VKORC1 多态性对黎巴嫩人群中华法林和醋硝香豆素的影响。
J Clin Pharmacol. 2011 Oct;51(10):1418-28. doi: 10.1177/0091270010382910. Epub 2010 Dec 8.
8
From pharmaco-therapy to pharmaco-prevention: trends in prescribing to older adults in Ontario, Canada, 1997-2006.从药物治疗到药物预防：1997-2006 年加拿大安大略省老年患者处方用药趋势。
BMC Fam Pract. 2010 Oct 7;11:75. doi: 10.1186/1471-2296-11-75.
9
Education may improve the underutilization of genetic services by Middle Eastern primary care practitioners.教育可能会改善中东地区初级保健从业者对基因服务利用不足的情况。
Genet Test Mol Biomarkers. 2010 Aug;14(4):447-54. doi: 10.1089/gtmb.2010.0021.
10
China: public health genomics.中国：公共卫生基因组学
Public Health Genomics. 2010;13(5):269-75. doi: 10.1159/000240969. Epub 2009 Sep 22.
Zotero 插件